SAN FRANCISCO--"California dreamin' on such a winter's day," sang the Mamas and the Papas. Exciting news poured out of the 32nd annual Heart Rhythm Society (HRS) meeting in San Francisco last week, which included the role of newer anticoagulants, novel technologies for patients who suffer from various heart rhythm disorders and a healthy debate around healthcare policy and reform. There is great hope that these promising results will be taken back and integrated into clinical practice.

Thursday, May 5 - Saturday, May 7

Wednesday, May 4, 8:00 a.m. 3:45 p.m., Room 130

Wednesday, May 4, 8am - 3:45pm

Wednesday, May 4, 4:15-5:45 pm

San Francisco, open your Golden Gate, sang Judy Garland.  When The Heart Rhythm Societys 32nd Annual Scientific Sessions kicks off tomorrow in San Francisco, a full agenda outlining the best strategies to treat cardiac arrhythmias and how healthcare reform will impact the field of EP, awaits attendees. This event features 250 educational sessions, 900 faculty and 130 exhibitors focused on research or delivery of arrhythmia care or services. The message is clear: successful collaboration among physicians, scientists, allied professionals and industry across the globe can dramatically improve patient care and outcomes. 

Implementing a multidisciplinary stroke clinic model into practice can improve care for high-risk cerebrovascular disease patients at almost the same cost as discharge to home, according to a study published in the April 26 issue of the Journal of Multidisciplinary Healthcare.

CHICAGOToday, cardiovascular services sit on the precipice of change, said Brian Contos, executive director of The Advisory Board Company, April 15 at the annual leadership meeting of the American College of Cardiovascular Administrators (ACCA).